HomeInsightsResults

Abbott India Ltd Quarterly Result

Abbott India Ltd Quarterly Result

stocks purchased

₹ 0.9 Cr

Volume Transacted

(Nov 21, 2024)

stocks purchased

0.3 K

Stocks Traded

(Nov 21, 2024)

Last Updated on: Nov 22, 2024

Image

Abbott India Ltd

NSE: ABBOTINDIA

Net Profit

₹ 358.61

Last updated on: Nov 22, 2024

Key Highlights

  • The revenue of Abbott India Ltd for the Sep '24 is ₹ 1693 crore as compare to the Jun '24 revenue of ₹ 1624 crore. This represent the growth of 4.1976986%.
  • The ebitda of Abbott India Ltd for the Sep '24 is ₹ 499.44 crore as compare to the Jun '24 ebitda of ₹ 458.34 crore. This represent the growth of 8.967143%.
  • The net profit of Abbott India Ltd for the Sep '24 is ₹ 358.61 crore as compare to the Jun '24 net profit of ₹ 328.01 crore. This represent the growth of 9.328976%.

Results Analysis

Market Price of Abbott India Ltd

1M

1Y

3Y

5Y

Monitoring Abbott India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 202427145.25
19 Nov 202427193.8
18 Nov 202427160.8
14 Nov 202427347
13 Nov 202427644.55
12 Nov 202428612.35
11 Nov 202428701.5
08 Nov 202428572.15
07 Nov 202428291.25
06 Nov 202429115.2

Historical Revenue of Abbott India Ltd

No data available

* All values are in crore

Historical EBITDA of Abbott India Ltd

No data available

* All values are in crore

Historical Net Profit of Abbott India Ltd

No data available

* All values are in crore

Abbott India Ltd News Hub

News

Board of Abbott India appoints director

The Board of Abbott India at its meeting held on 07 November 2024 has approved the appoint...

Read more

07 Nov 202415:16

News

Abbott India to announce Quarterly Result

Abbott India will hold a meeting of the Board of Directors of the Company on 7 November 20...

Read more

29 Oct 202412:27

News

Abbott India director resigns

Abbott India announced the resignation of Ashok Saini as Commercial Director - GenNext, Va...

Read more

18 Oct 202412:03

News

Abbott India joins hand with Takeda Pharma to launch Vonoprazan tablets in India

Vonoprazan (PCAB or potassium competitive acid blocker) addresses severe acid related diso...

Read more

20 Sep 202410:37

News

Abbott India to declare Quarterly Result

Abbott India will hold a meeting of the Board of Directors of the Company on 7 August 2024...

Read more

30 Jul 202417:09

News

Abbott India appoints director

Abbott India has appointed Alison Davies (DIN: 10658884) as an Additional Non-Executive Di...

Read more

12 Jun 202417:57

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Abbott India Ltd Quarterly Result

What is the EPS of Abbott India Ltd stock?

The Earnings Per Share (EPS) of Abbott India Ltd is 604.55. An EPS is the amount of net income attributed to each share of a common stock.

How is Abbott India Ltd EPS calculated?

The EPS of Abbott India Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Abbott India Ltd report its EPS?

Abbott India Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Abbott India Ltd EPS?

Factors that influence the EPS of Abbott India Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Abbott India Ltd EPS growth indicate future performance?

Yes, consistent growth in Abbott India Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*